212 related articles for article (PubMed ID: 17596645)
41. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies.
Gabizon A; Horowitz AT; Goren D; Tzemach D; Mandelbaum-Shavit F; Qazen MM; Zalipsky S
Bioconjug Chem; 1999; 10(2):289-98. PubMed ID: 10077479
[TBL] [Abstract][Full Text] [Related]
42. Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo.
Leamon CP; Cooper SR; Hardee GE
Bioconjug Chem; 2003; 14(4):738-47. PubMed ID: 12862426
[TBL] [Abstract][Full Text] [Related]
43. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
[TBL] [Abstract][Full Text] [Related]
44. Folate receptor targeted delivery of polyelectrolyte complex micelles prepared from ODN-PEG-folate conjugate and cationic lipids.
Kim SH; Jeong JH; Mok H; Lee SH; Kim SW; Park TG
Biotechnol Prog; 2007; 23(1):232-7. PubMed ID: 17269693
[TBL] [Abstract][Full Text] [Related]
45. Receptor-mediated gene delivery by folate-PEG-baculovirus in vitro.
Kim YK; Choi JY; Yoo MK; Jiang HL; Arote R; Je YH; Cho MH; Cho CS
J Biotechnol; 2007 Sep; 131(3):353-61. PubMed ID: 17727999
[TBL] [Abstract][Full Text] [Related]
46. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate.
Kim SH; Jeong JH; Chun KW; Park TG
Langmuir; 2005 Sep; 21(19):8852-7. PubMed ID: 16142970
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and in vitro/in vivo evaluation of 99mTc-labeled folate conjugates for folate receptor imaging.
Lu J; Pang Y; Xie F; Guo H; Li Y; Yang Z; Wang X
Nucl Med Biol; 2011 May; 38(4):557-65. PubMed ID: 21531293
[TBL] [Abstract][Full Text] [Related]
48. Peptide-based pharmacomodulation of a cancer-targeted optical imaging and photodynamic therapy agent.
Stefflova K; Li H; Chen J; Zheng G
Bioconjug Chem; 2007; 18(2):379-88. PubMed ID: 17298029
[TBL] [Abstract][Full Text] [Related]
49. Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol).
Liu L; Zheng M; Librizzi D; Renette T; Merkel OM; Kissel T
Mol Pharm; 2016 Jan; 13(1):134-43. PubMed ID: 26641134
[TBL] [Abstract][Full Text] [Related]
50. Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate.
Moon WK; Lin Y; O'Loughlin T; Tang Y; Kim DE; Weissleder R; Tung CH
Bioconjug Chem; 2003; 14(3):539-45. PubMed ID: 12757377
[TBL] [Abstract][Full Text] [Related]
51. Increased uptake of folate conjugates by activated macrophages in experimental hyperlipemia.
Antohe F; Radulescu L; Puchianu E; Kennedy MD; Low PS; Simionescu M
Cell Tissue Res; 2005 May; 320(2):277-85. PubMed ID: 15714274
[TBL] [Abstract][Full Text] [Related]
52. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y
Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651
[TBL] [Abstract][Full Text] [Related]
53. Tumor cell targeting using folate-conjugated fluorescent quantum dots and receptor-mediated endocytosis.
Song EQ; Zhang ZL; Luo QY; Lu W; Shi YB; Pang DW
Clin Chem; 2009 May; 55(5):955-63. PubMed ID: 19282359
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical.
Leamon CP; Parker MA; Vlahov IR; Xu LC; Reddy JA; Vetzel M; Douglas N
Bioconjug Chem; 2002; 13(6):1200-10. PubMed ID: 12440854
[TBL] [Abstract][Full Text] [Related]
55. Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis.
Turk MJ; Breur GJ; Widmer WR; Paulos CM; Xu LC; Grote LA; Low PS
Arthritis Rheum; 2002 Jul; 46(7):1947-55. PubMed ID: 12124880
[TBL] [Abstract][Full Text] [Related]
56. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
Scomparin A; Salmaso S; Eldar-Boock A; Ben-Shushan D; Ferber S; Tiram G; Shmeeda H; Landa-Rouben N; Leor J; Caliceti P; Gabizon A; Satchi-Fainaro R
J Control Release; 2015 Jun; 208():106-20. PubMed ID: 25869964
[TBL] [Abstract][Full Text] [Related]
57. 99mTc-HYNIC-folate: a novel receptor-based targeted radiopharmaceutical for tumor imaging.
Guo W; Hinkle GH; Lee RJ
J Nucl Med; 1999 Sep; 40(9):1563-9. PubMed ID: 10492380
[TBL] [Abstract][Full Text] [Related]
58. Exploratory study of 99mTc-EC20 imaging for identifying patients with folate receptor-positive solid tumors.
Fisher RE; Siegel BA; Edell SL; Oyesiku NM; Morgenstern DE; Messmann RA; Amato RJ
J Nucl Med; 2008 Jun; 49(6):899-906. PubMed ID: 18483093
[TBL] [Abstract][Full Text] [Related]
59. In vivo antitumor activity of folate receptor-targeted liposomal daunorubicin in a murine leukemia model.
Pan XQ; Lee RJ
Anticancer Res; 2005; 25(1A):343-6. PubMed ID: 15816557
[TBL] [Abstract][Full Text] [Related]
60. Efficient delivery of an antisense oligodeoxyribonucleotide formulated in folate receptor-targeted liposomes.
Chiu SJ; Marcucci G; Lee RJ
Anticancer Res; 2006; 26(2A):1049-56. PubMed ID: 16619505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
